ROBIN MARIE RATHE MD
Prescription History 1962847848
Obstetrics & Gynecology in Los Angeles, CA

Active since May 06, 2013PECOS Enrolled
200 UCLA MEDICAL PLZ STE 430, LOS ANGELES, CA 90095(310) 794-7274 Get Directions

NPPES record last updated: May 17, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: May 17, 2021, Jan 28, 2021, Sep 25, 2018 and 1 more (4 updates tracked since 2017).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ROBIN MARIE RATHE MD, an active Obstetrics & Gynecology specialist practicing in Los Angeles, CA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
22
30-Day Fills
Estradiol
Most Prescribed · 12 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by ROBIN MARIE RATHE MD in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
Estradiol12$47.28▼ below CA avg▼ Less than typical

About Estradiol: This medication is a hormone. Show more ▾

It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2024, this provider wrote 12 Medicare prescriptions for Estradiol, about a third of the volume of the typical California prescriber of this medication (37.9). Medicare paid an average of $47.28 per fill, versus $56.87 statewide.

How often this provider prescribes it

This provider
12
CA average
37.9

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$47.28
CA average
$56.87

This provider's average cost per fill is below the CA average for this medication.

22
30-Day Fills
standardized to 30-day supplies
660
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for ROBIN MARIE RATHE MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Los Angeles, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.